EUVIMEDOpdag EUVIMED
Crossref

Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification

Danieli B Salinas iD, Daniella K Ginsburg, Choo Phei Wee, Muhammed M Saeed, John J Brewington

Pediatric Pulmonology · 2023

DOI: 10.1002/ppul.26296 ↗

At a glance

Journal article in Pediatric Pulmonology, 2023. Written by Danieli B Salinas and 4 co-authors. Institution: Department of Pediatrics, Division of Pediatric Pulmonology, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern Califor…. Major MEDLINE topics: Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis. Cited 16 times so far (Crossref); 42 references. Funded by: Cystic Fibrosis Foundation, National Center for Advancing Translational Sciences.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objectives

Universal implementation of cystic fibrosis (CF) newborn screening (NBS) has led to the diagnostic dilemma of infants with CF screen‐positive, inconclusive diagnosis (CFSPID), with limited guidance regarding prognosis and standardized care. Rates of reclassification from CFSPID to CF vary and risk factors for reclassification are not well established. We investigated whether clinical characteristics are associated with the risk of reclassification from CFSPID to a CF diagnosis.

Methods

Children with a positive CF NBS were recruited from two sites in California. Retrospective, longitudinal, and cross‐sectional data were collected. A subset of subjects had nasal epithelial cells collected for CF transmembrane conductance regulator (CFTR) functional assessment. Multivariate logistic regression was used to assess the risk of reclassification.

Results

A total of 112 children completed the study (CF = 53, CFSPID = 59). Phenotypic characteristics between groups showed differences in pancreatic insufficiency prevalence, immunoreactive trypsinogen (IRT) levels, and Pseudomonas aeruginosa (PSA) colonization. Spirometry measures were not different between groups. Nasal epithelial cells from 10 subjects showed 7%–30% of wild‐type (WT)‐CFTR (wtCFTR) function in those who reclassified and 27%–67% of wtCFTR function in those who retained the CFSPID designation. Modeling revealed that increasing sweat chloride concentration (sw[Cl − ]) and PSA colonization were independent risk factors for reclassification to CF.

Conclusion

Increasing sw[Cl − ] and a history of PSA colonization are associated with the risk of reclassification from CFSPID to CF in a population with high IRT and two CFTR variants. A close follow‐up to monitor phenotypic changes remains critical in this population. The role of CFTR functional assays in this population requires further exploration.

Subjects

MeSH terms (MEDLINE)

Cystic Fibrosis Transmembrane Conductance RegulatorCystic FibrosisInfantInfant, NewbornChildHumansChloridesNeonatal ScreeningRetrospective StudiesSweatCross-Sectional StudiesTrypsinogen

Author keywords

CFSPIDCRMScystic fibrosisnewborn screening

Substances

Cystic Fibrosis Transmembrane Conductance RegulatorChloridesTrypsinogen

Authors and institutions

  • Department of Pediatrics, Division of Pediatric Pulmonology, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Department of Population and Public Health Sciences, Keck School of Medicine, Southern California Clinical and Translational Science Institute (SC-CTSI), University of Southern California, Los Angeles, California, USA.
  • Division of Pediatric Pulmonology, Kaiser Permanente Los Angles Medical Center, Los Angeles, California, USA.
  • Department of Pediatrics, Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

ORCID profiles: Danieli B Salinas

Funding

  • Cystic Fibrosis Foundation
  • National Center for Advancing Translational Sciences

Cite

APA

Salinas, D. B., Ginsburg, D. K., Wee, C. P., Saeed, M. M., & Brewington, J. J. (2023). Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26296

Vancouver

Salinas DB, Ginsburg DK, Wee CP, Saeed MM, Brewington JJ. Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26296

BibTeX
@article{Salinas2023,
  author = {Salinas, Danieli B and Ginsburg, Daniella K and Wee, Choo Phei and Saeed, Muhammed M and Brewington, John J},
  title = {Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification},
  journal = {Pediatric Pulmonology},
  year = {2023},
  doi = {10.1002/ppul.26296}
}
Start for free →